392 trials
Primary Ciliary Dyskinesia
Primary: Baseline MCC (Ave60Clr; Average Clearance Over 60 Minutes) — 1.4; -1.1; 7.3 percent clearance — p=0.002
Chronic Spontaneous Urticaria
Primary: Reduction in Urticaria Activity Score (UAS7) — 3; 7 Participants
Cervical Carcinoma · Malignant Female Reproductive System Neoplasm · Vaginal Carcinoma
Primary: Number of Sentinel Lymph Nodes (SLNs) Identified by Lymphosonography as Well as Blue Dye or Positron Emission Tomography (PET)-Computed Tomography (CT) — 17 sentinel…
Spinal Cord Injury
Primary: Urethral Sphincter Pressure — 50 cmH2O
Chronic Actinic Dermatitis
Primary: 50% Reduction in the Eczema Area and Severity Index Score (EASI-50) — 12; 9 Participants
Stroke
Primary: Maximum Cross-correlation Coefficient — 0.989; 0.945; 0.995; 0.996 cross-correlation coefficient — p=<0.001
Interaction · Endogenous Biomarkers
Primary: Metformin Area Under the Concentration vs. Time Curve (AUC) — 830 mcg*h/L
Healthy · Elderly
Primary: Maximum Human Plasma Concentration of Bioactives From Centella Asiatica. — 174; 372; 0.3; 0.5 ng/mL
Cocaine Use Disorder
Primary: Reinforcing Effects of Cocaine — 1.4; 4; 4.5; 0.7 number of times subjects chose cocaine
Tobacco Use · Smoking Cessation · Nicotine Dependence
Primary: Feasibility of Ketamine Treatment for Tobacco Use Disorder — 7 Participants
Preeclampsia Postpartum
Primary: Cutaneous Conductance (%Maximum) Response to Acetylcholine — 89.4; 72.5 % of maximal cutaneous conductance
Cerebral Palsy
Primary: Device Feasibility — 33.33 percent time EMG taVNS stimulation
Lung Cancer, Nonsmall Cell
Primary: Data on Whole-body Pharmacokinetics of [18F]F-AraG Physiologic Uptake in Various Healthy Tissues — 0.31; 4.36; 0.04; 32.88 SUV
Stroke
Primary: Change in Action Research Arm Test (ARAT) Total Score From Baseline to Post-Intervention — 0.72; 0 Units on a scale
Nicotine Dependence · Smoking, Cigarette · Smoking Cessation
Primary: Craving Intensity to Smoking Cues — 40.50; 50.44 units on a scale